ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury

Exclusion Criteria

• •1. Must not be pregnant nor breastfeeding.
• •2. Must not have brain damage.
• •3. Must not have a history of epilepsy
• •4. Must not have participated in another clinical study using drugs or medical devices within the 30 days preceding and during the present study.
• •5. Must not have previously been injected with stem cells in the spinal cord.
• •6. Must not have any diseases and conditions that would increase the morbidity and mortality of SCI surgery.
• •7. Must not require ventilator support.
• •8. Must not have any existing contraindication to mobility functions (e.g., unhealed bone fractures, central nervous system disorder, peripheral nerve disorder, etc.).
• •9. Must not suffer from SCI from other etiology than trauma (ischemic, tumoral, autoimmune, etc.).
• •10. Must not have any anatomical limitations in the implantation area as judged by the investigators (e.g., spinal stenosis, limiting protrusions, post-traumatic bone damage at area of implantation).
• •11. Must not require the use of an intrathecal baclofen pump.
• •12. Must not have any active implanted devices.
• •13. Must not have any other conditions that would make the subject unable to participate in testing in the judgment of the investigators (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.).
• •14. Must not be the investigator him/herself, his/her family members, employees or other dependent persons.